Price of Pemigatinib after launch in China

Pemigatinib (Pemigatinib)The original drug has been approved under the relevant regulations of the State Food and Drug Administration and is sold in hospitals or pharmacies under the name of Pemigatinib tablets (trade name: Dabotan/PEMAZYRE). The common specifications are 4.5mg and 9mg preparations. Since they have not been included in medical insurance, the price is relatively expensive. The price of each box of 4.5mg*14 tablets may be around 30,000 RMB, and the price of each box of 9mg*14 tablets may be around 50,000 RMB.

Pemetinib is approved for the treatment of adults with locally advanced or metastatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) fusions or rearrangements that have progressed after at least one prior systemic therapy. It is also the first targeted therapy approved in the United States for the treatment of adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with FGFR1 rearrangements. Pemetinib is well tolerated, and common adverse reactions include hyperphosphatemia, alopecia, diarrhea, fatigue, dysgeusia, nausea, and stomatitis.

The original drug Pemetinib currently marketed overseas is also relatively expensive. The price of each box of 13.5mg*14 tablets may be around RMB 70,000 (the price may fluctuate due to exchange rates). There are also generic pemetinib drugs produced in other countries overseas, and their drug ingredients are basically the same as those of the original drugs sold abroad. For example, the price of 4.5mg*14 tablets per box produced by a Laos pharmaceutical factory may be around 1,000 yuan (the price may fluctuate due to exchange rates). For more drug information and specific prices, please consult Yaode Medical Consultant.